polatuzumab vedotin
roche
['lymsm', 'thanks', 'pola']
more gi toxicity in pola-r-minichp arm. any explanation? of notice, tolerability of new therapies in older patients may be different than in youngers. thanks for generating the evidence #lymsm #geriheme #eha2023 
Lymphoma Unit @Hospital_FJD & @UICOquironsalud. Board member @sehh_es & @EHA_Hematology. Chair, SWG “Aging and Hematology”. @ASH_hematology IMC member